home / stock / ipn / ipn news

IPN News and Press, SPDR S&P International Industrial Sector From 09/10/19

Stock Information
Company Name: SPDR S&P International Industrial Sector
Stock Symbol: IPN
Market: NYSE
Menu
IPN IPN Quote IPN Short IPN News IPN Articles IPN Message Board
Get IPN Alerts

News, Short Squeeze, Breakout and More Instantly...
IPN - Ipsen and Servier announce initial Phase II/III clinical data evaluating investigational liposomal irinotecan (ONIVYDE®) as a second-line treatment for small cell lung cancer (SCLC) at the IASLC 2019 World Conference on Lung Cancer

Ipsen and Servier announce initial Phase II/III clinical data evaluating investigational liposomal irinotecan (ONIVYDE®) as a second-line treatment for small cell lung cancer (SCLC) at the IASLC 2019 World Conference on Lung Cancer Canada NewsWire MONTREAL, Sept. 10, 2019 ...
IPN - Ipsen and Servier announce initial Phase 1/2 clinical data evaluating liposomal irinotecan (ONIVYDE®) as an investigational first-line treatment for metastatic pancreatic cancer at ESMO 21st World Congress on Gastrointestinal Cancer

Ipsen and Servier announce initial Phase 1/2 clinical data evaluating liposomal irinotecan (ONIVYDE®) as an investigational first-line treatment for metastatic pancreatic cancer at ESMO 21st World Congress on Gastrointestinal Cancer Canada NewsWire LAVAL, QC, July 5, 2019 ...

IPN - Ipsen's Dysport® (Clostridium Botulinum Type a Toxin-haemagglutinin Complex) Becomes First and Only Botulinum Toxin Type A to be Granted a Licence Update for Administration by Healthcare Professionals, Such as Physiotherapists, in the UK

New authorisation recognises the role of non-medical injectors (NMIs) such as physiotherapists in focal spasticity and advances standards of care SLOUGH, England , June 5, 2019 /PRNewswire/ -- Ipsen (Euronext: IPN; ADR: IPSEY) today announced that the Medicines and Healthcare Products...

Previous 10 Next 10